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We used cDNA microarray to identify transforming growth factor beta (TGF-b) responsive target
genes during osteoblast development and found that nephronectin (Npnt) is one such gene that
is signiﬁcantly down-regulated. Here we report the role of TGF-b in regulating Npnt-mediated osteo-
blast differentiation. We found that the effect of TGF-b on Npnt expression is associated with a
change in cell morphology in a dose-dependent manner. Npnt-induced osteoblast differentiation
was also inhibited by TGF-b, which changed cell morphology from cuboidal to ﬁbroblastic, an indi-
cation that osteoblast differentiation was disrupted. Furthermore, TGF-b inhibited differentiation of
osteoblasts transfected with various truncated Npnt constructs, suggesting that TGF-b can exert a
down-stream effect on Npnt function. Our results suggest that TGF-b can inhibit osteoblast differen-
tiation through various mechanisms.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Nephronectin (Npnt) is an extracellular matrix (ECM) molecule,
which was initially detected in the developing mouse kidney as a
novel ligand for the integrin a8b1 [1]. Npnt was shown to be ex-
pressed in various tissues other than the kidney including the
eye, ear, choroids plexus, jaw, lung, and taste buds, and was also
recognized by various RGD-binding integrins including aVb3,
aVb5, aVb6, a4b7. Hence, this molecule may play a wide range
of roles in cell differentiation and tissue development [1–3]. Previ-
ous studies have found that Npnt is down-regulated by TGF-b1
during osteoblast development [4].
Transforming growth factor-bs (TGF-bs) are known to modulate
cell proliferation, differentiation, apoptosis, adhesion, migration,
and to known favor the production of ECM proteins such as ﬁbro-
nectin [5,6]. Divergent effects of TGF-b on bone formation have
been reported both in vitro and in vivo [7,8]. In fetal rat calvariachemical Societies. Published by E
beta; PAGE, polyacrylamide
phosphatase; ECM, extracel-
iences Centre, 2075 Bayviewosteoblasts, TGF-b has been demonstrated to repress the expres-
sion of most osteoblastic proteins [7,9]. Previous studies have
shown that TGF-b plays an inhibitory effect on Npnt synthesis
[10]. In the early studies, we have demonstrated that Npnt pro-
motes osteoblast differentiation which can be modulated by micr-
oRNA miR-378 [11]. In addition, different domains of Npnt exert
distinct roles in mediating osteoblast differentiation [12]. In this
study, we further examined the role of TGF-b in regulating Npnt
expression and in Npnt-induced osteoblast differentiation.
2. Materials and methods
2.1. Cell culture
MC3T3-E1 cells (from ATCC) were cultured in differentiation
medium which contained 50 lg/ml ascorbic acid, 10 mM b-glycer-
ophosphate, and 108 M dexamethasone in a-MEM. The culture
medium was changed every 3 days. Staining of alkaline phospha-
tase (ALP) activity was used to identify cell differentiation. In brief,
the cells were ﬁxed with formalin (10% formaldehyde in PBS). After
removal of the ﬁxation solution and successive washes with
distilled water, the cells were stained with staining solution
(1 mg/ml Naphthol AS-MX-PO4; 6 mg/ml fast red violet LB salt,
in 10 mM Tris–HCl, pH 8.0) at 37 C for 45 min. After removal oflsevier B.V. All rights reserved.
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were subjected to microscopic examination using different phases
to identify positive cells with ALP activity.
2.2. RNA isolation and analysis
The methods of RNA isolation and Northern hybridization have
been described in detail previously [12]. For RT-PCR analysis, total
RNA was extracted from 1  106 cells using RNeasy mini kit (Qia-
qen Inc., ON, Canada). The cDNAs were synthesized by superscript
II reverse transcriptase using freshly prepared RNA (2 lg) as tem-
plate. The PCR was performed using the cDNA as template and
appropriate primers by RedTaq DNA polymerase. PCR reactions
were carried out as follows: one cycle at 94 C for 5 min; 35 cycles
at 94 C for 60 s, 56 C for 30 s, 72 C for 60 s; and a ﬁnal elongation
step at 72 C for 5 min, with primer pairs 50gaggaccctctctctgc
tcactct and 50gcaaggggatttgggggcttaggg for Osteocalcin, 50aagactgc
tttaattttgctcagc and 50cttcattcccctcagaatcttcat for integrin-binding
sialoprotein (IBSP); and 50atggtgaaggtctgtgtgatcatc and 50tgggttct
cactcctggaagaagg for GAPDH.
2.3. ALP
We followed our previous description for the staining of ALP
activity [4,12].
2.4. Western blot
Cells were harvested using 100mM EDTA at 60–80% conﬂuency
and washed three times with PBS. Cell lysates were prepared and
protein concentrations were quantiﬁed. Lysates were subjected
to SDS–polyacrylamide gel electrophoresis and the separated pro-
teins were transferred onto a nitrocellulose membrane followed by
blocking and incubation in a primary monoclonal antibody at 4 de-
grees overnight. After washing, the membranes were incubated
with HRP-conjugated goat-anti-mouse secondary antibody at
room temperature for 1 h followed by ECL detection. The detailed
procedure was described by us previously [13–16].
2.5. Statistical analysis
The results (mean values ± S.D.) of all of the experiments were
subjected to statistical analysis by Student’s t-test. The level of sig-
niﬁcance was set at P < 0.05.
3. Results
3.1. TGF-b1 inhibits Npnt expression and altered cell morphology
To conﬁrm the microarray results showing down-regulation of
Npnt mRNA in MC3T3-E1 cells treated with TGF-b1, we assessed
the minimum time required by these ligands to exert their effects
on Npnt mRNA expression in the osteoblasts. MC3T3-E1 cells were
treated with TGF-b1 and total RNA was extracted at various time
points. At each time point, RNA was also extracted from a ‘‘control
plate” consisting of MC3T3-E1 cells that had not received any
treatment. A decrease in Npnt expression was observed 4 h after
TGF-b1 treatment, while a signiﬁcant down-regulation was ob-
served after 8 h treatment (Fig. 1A). The cells were also treated
with different TGF-b1 constructs for different intervals. Cell mor-
phology was examined under a light microscope. We found that
at higher concentrations of TGF-b1, cells started to change mor-
phology at 3.5 h (Fig. 1B). With a concentration as low as 1 ng, al-
tered cell morphology could be detected after overnight culture.
We analyzed expression of osteoblast differentiation by RT-PCR
in order to conﬁrm that the change in cell morphology wasassociated with osteoblast differentiation. We found that inte-
grin-binding sialoprotein could be detected on day 6 and its
expression was down-regulated by TGF-b (Fig. 1C). On the other
hand, expression of Osteocalcin was not affected by TGF-b treat-
ment. We also found that ALP activity was inhibited by TGF-b
treatment (Fig. 1D).
3.2. TGF-b1 inhibited Npnt-induced osteoblast differentiation
To study the role of Npnt during osteoblast development, we ex-
pressed the full-length Npnt in MC3T3-E1 cells. Conditioned med-
ium from two stable cell lines were examined for successful
expression and secretion of the exogenous Npnt protein by western
blotting (Fig. 2A). The cell lines were grown in culture medium for
induction of osteoblast differentiation. One set of cells was treated
with TGF-b1, while the other set was left untreated. Expression of
ALP was analyzed. The Npnt-transfected cells displayed much high-
er levels of ALP expression than those transfected with the empty
vector (Fig. 2B). On the other hand, treatment with TGF-b1 showed
a decrease in ALP expression in the cells over-expressing Npnt as
well as in the cells transfected with the empty vector. The same
areas were also examined under a different phase of the light micro-
scope and this allowed quantiﬁcation of ALP expression. Impor-
tantly, treatment with TGF-b1 resulted in a signiﬁcant decrease in
ALP expression even in the Npnt over-expressing cells (Fig. 2C).
Our results indicate that TGF-b1 can play a role in down-regulating
and/or blocking the effects of Npnt over-expression, leading to
down-regulation of osteoblast differentiation.
Proliferating MC3T3-E1 cells normally display a ‘‘ﬁbroblastic”
morphology, while differentiating cells are characterized by a
‘‘cuboidal” morphology. However, when proliferating cells were
treated with TGF-b1, differentiation was inhibited and thereby
they remained in their proliferative phase as ﬁbroblastic-appearing
cells [4]. The cells transfected with the empty vector or Npnt pro-
ceeded normally from ﬁbroblastic to cuboidal morphology as they
entered into the differentiation phase. The addition of TGF-b1
inhibited differentiation and thus the cells maintained a ﬁbroblas-
tic morphology (Fig. 2D), in addition to experiencing prolonged
proliferation and the absence/delay of differentiation. In fact, long-
er treatment of TGF-b1 altered cell morphology to a greater extent
(Fig. 2E).
3.3. TGF-b1 affects the essential domain of Npnt on osteoblast
differentiation
We have previously demonstrated that transfecting a truncated
Npnt construct containing EGF-repeats (Np-EGF) into osteoblasts
strongly enhances their differentiation [12]. We exposed MC3T3-
E1 cells stably transfected with the Np-EGF construct to TGF-b. In
the absence of TGF-b1 treatment, the Np-EGF-transfected cells
exhibited a cuboidal morphology and produced extremely high
levels of ALP expression, indicating the occurrence of osteoblast
differentiation (Fig. 3A). When the cells were treated with TGF-
b1, these cells exhibited a ﬁbroblastic morphology and expressed
much lower levels of ALP, indicating that TGF-b1 treatment
down-regulated differentiation (Fig. 3A). This difference was found
to be signiﬁcant when the cells expressing ALP were quantiﬁed and
subjected to statistical analysis. Fig. 3B shows what was typically
seen.
We further investigated the effect of TGF-b1 on the differentia-
tion of MC3T3-E1 cells transfected with the Np-MAM construct.
We have previously shown that Np-MAM-transfected cells exhibit
a much lower level of ALP expression than vector-transfected cells
[12]. These cells also displayed ﬁbroblastic morphology. When the
cells were treated with TGF-b1, we detected a further decrease in
ALP expression in the Np-MAM-transfected cells as compared with
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Fig. 1. Nephronectin expression and cell morphology are affected by TGF-b1. (A) MC3T3-E1 cells were treated with or without 10 ng/ml TGF-b1 for 24 h. Total RNA was
analyzed on Northern blot. (B) MC3T3-E1 cells were treated with different concentrations of TGF-b1 for different intervals. Cell morphology was monitored under a light
microscope. Scale bar, 50 lm. (C) MC3T3-E1 cells were cultured in the differentiation inducing medium and treated with different concentrations of TGF-b1 for 6 days. The
cells culture in regular medium without TGF-b treatment served as a control (ctrl). Total RNA was isolated for RT-PCR analysis to detect expression of Osteocalcin, integrin-
binding sialoprotein (IBSP), and GAPDH. (D) MC3T3-E1 cells were cultured in the differentiation inducing medium and treated with or without TGF-b1 (10 ng/ml) for 6 days,
followed by staining for ALP activity. Typical micrographs of ALP expression were taken using two different phases (upper and lower panels) of the microscope for better
estimation of ALP activity. Scale bar, 50 lm.
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Fig. 2. Osteoblast differentiation is enhanced by nephronectin but inhibited by TGF-b1. (A) Upper, A full-length nephronectin construct was generated containing the ﬁve
EGF-like repeats, RGD domain, and the MAM domain. A leading peptide (LP) was tagged at the N-terminal region of the construct. Lower, After transfection, conditioned
medium was analyzed on western blot probed with the monoclonal antibody 4B6 which recognizes an epitope in the leading peptide, to conﬁrm expression and secretion of
the protein in cell lines stably transfected with the construct. (B) Two nephronectin- and two vector-transfected MC3T3-E1 cell lines were grown for 10 days and stained for
ALP expression. Nephronectin expression enhanced ALP activity. Typical micrographs of ALP expression in the two clones were taken using two different phases (upper and
lower panels) of the microscope for better estimation of ALP activity. Scale bars, 100 lm. (C) Nephronectin- and vector-transfected cells were cultured for 6 days and treated
with or without 10 ng/ml TGF-b1. The cells were stained for ALP expression. Using two different phases of the microscope, the ALP positive cells were counted and quantiﬁed
(n = 3, **P < 0.01). (D) Nephronectin- and vector-transfected cells were grown for 6 days and treated with or without 10 ng/ml TGF-b1. The cells were examined for changes in
morphology. The upper micrographs show regular morphology in the absence of treatment. The lower micrographs show a ﬁbroblast-like morphology after treatment with
10 ng/ml TGF-b1 for 6 days. Scale bar, 50 lm. (E) The nephronectin-transfected cells were treated with or without TGF-b1 (10 ng/ml). Cell morphology was monitored under a
light microscope. Scale bar, 50 lm.
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Fig. 3. EGF-repeats-mediated cell differentiation is inhibited by TGF-b1. (A) A
truncated nephronectin construct was generated containing the EGF-like repeats,
named Np-EGF (upper). Np-EGF- and vector-transfected cells were grown for 6 days
and treated with or without 10 ng/ml TGF-b1 (two treatments, lower). TGF-b
treatment inhibited cell differentiation. (B) The cells were examined for changes in
morphology. Typical micrographs of cell morphology and ALP expression are
shown. Scale bar, 50 lm.
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Fig. 4. TGF-b1 exerts minimal effect on the RGD and MAM domains of nephronec-
tin. (A) The ﬁve EGF-like repeats were deleted to generate a truncated nephronectin
construct containing only the RGD and MAM domains (upper). Np-MAM- and
vector-transfected cells were grown for 6 days and treated with or without 10 ng/
ml TGF-b1. The cells were stained for ALP expression. Stained cells were counted for
quantitative analysis. While differentiation was inhibited by Np-MAM expression,
addition of TGF-b1 further inhibited cell differentiation (n = 3, **P > 0.001, lower).
(B) Typical micrographs of cell morphology and ALP expression are shown. The
morphology of both groups appeared similar. Scale bar, 50 lm.
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phology was not as obvious as those indicated above (Fig. 4B).
Since cells transfected with the Np-MAM construct had already ob-
tained a ﬁbroblastic morphology, treatment with TGF-b1, which
normally drives cells from a cuboidal to ﬁbroblastic morphology
appeared to affect the Np-MAM-transfected cells very minimally.
These results suggest that the MAM domain plays a negative effect
on osteoblast differentiation, and that treatment with TGF-b1 fur-
ther exacerbates that effect.
4. Discussion
Bone matrix contains high concentrations of growth factors
belonging to the TGF-b superfamily, which regulate cell prolifera-
tion, differentiation, protein synthesis, secretion, and deposition
of ECM [5]. To understand the consequences of signaling induced
by these molecules during bone development, we used cDNA
microarray to identify TGF-b associated gene expression during
osteoblast development [4]. We observed that Npnt was one of
the genes that was signiﬁcantly down-regulated by TGF-b1 duringosteoblast development (differential expression = 5.2). Npnt, an
extracellular molecule and a novel ligand for integrin a8b1, was
discovered in the developing mouse kidney [1,2]. In this study,
we conﬁrmed the microarray results by analyzing Npnt expression.
To understand the down-regulatory effect of TGF-b1 on Npnt
expression, we analyzed Npnt mRNA levels after short term treat-
ment with TGF-b1. Our Northern blot results showed that Npnt
mRNA is ﬁrst down-regulated approximately 4 h after TGF-b1
treatment. This is consistent with the effect of TGF-b1 treatment
on change of cell morphology. To corroborate this result, we also
analyzed expression of markers associated with osteoblast differ-
entiation by RT-PCR. Our results showed that change in cell mor-
phology was tightly related to markers known to highlight
osteoblast differentiation.
The ALP enzyme is essential for the commitment of mesenchymal
cells to the osteoblast lineage and only differentiated osteoblasts
stain pink for ALP expression. Hence, ALP was appropriately used
as a marker to distinguish proliferating MC3T3-E1 cells from differ-
entiating ones. There was a signiﬁcant difference in ALP expression
between MC3T3-E1 cells transfected with the empty vector and
2882 L. Fang et al. / FEBS Letters 584 (2010) 2877–2882those expressing full-length Npnt. We have shown earlier that treat-
ment with TGF-b1 down-regulates ALP expression and differentia-
tion [4]. To further our understanding in this respect, we studied
the role of TGF-b1 in ALP expression and its modulation of Npnt in
osteoblast differentiation. Since over-expression of Npnt was seen
to enhance ALP expression and differentiation in the stable cells
[11], we examined whether or not treatment with TGF-b1 could
block this effect. Indeed, we observed that treatment with TGF-b1
down-regulated ALP expression and differentiation in all MC3T3-
E1 cell lines stably transfected with Npnt and the other constructs
containing the essential Npnt domains. TGF-b1 was effective in
blocking the roles of ‘‘exogenous” expressed Npnt on osteoblast dif-
ferentiation, and thus it is possible that TGF-b1 exerts its inhibitory
effect on osteoblasts by inhibiting Npnt expression or by blocking
Npnt signalling. Mechanisms underlying the stimulatory effect that
Npnt has on osteoblast differentiation and the inhibitory effect that
TGF-b1 has on Npnt-induced osteoblast differentiation remain to be
investigated.
When MC3T3-E1 cells are proliferating, they maintain a ‘‘ﬁbro-
blastic” morphology. When the cells begin to differentiate, they be-
come ‘‘cuboidal” in shape. This change in morphology is inhibited
when MC3T3-E1 cells were treated with TGF-b1. In fact, cells trea-
ted with TGF-b1 exhibited elongation in shape. Interestingly, the
cells transfected with the empty vector were not the only ones
affected by TGF-b1: the cells transfected with full-length Npnt
and truncated Npnt lacking the RGD and the MAM domains were
also affected by TGF-b1. Cells transfected with the truncated Npnt
construct lacking ﬁve EGF-like repeats, namely the Np-MAM
construct, were unable to differentiate. Thus, they were unable to
follow the normal pattern of switching from ﬁbroblastic to cuboi-
dal morphology. As a result, the effect of TGF-b1 on these cells was
minimal. These cells retained their ﬁbroblastic morphology and
appeared extremely elongated with or without TGF-b1 treatment.
On the other hand, differentiation of cells transfected with
Np-EGF, which should greatly induce osteoblast differentiation,
was also signiﬁcantly inhibited with TGF-b1 treatment. This result
further suggests that TGF-b1 functions down-stream of the
expressed product.
In summary, we demonstrated that TGF-b1 inhibits osteoblast
differentiation in multiple ways. TGF-b1 down-regulates endoge-
nous Npnt expression, leading to the inhibition of osteoblast differ-
entiation. TGF-b1 also down-regulates osteoblast differentiation in
the presence of exogenously expressed Npnt probably by down-
regulating a molecule down-stream of Npnt, thus blocking the ef-
fect of Npnt on inducing osteoblast differentiation.Acknowledgements
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